Surgical margins for resection of primary cutaneous melanoma

Clinics in Dermatology

Volumn 22, Issue 3, 2004, Pages 228-233

  Cook, Joel ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; LONG TERM CARE; MELANOMA; PREDICTION; PRIORITY JOURNAL; REVIEW; SKINFOLD THICKNESS; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 3242674268     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.009     Document Type: Article

References (77)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., et al. Cancer statistics, 2001. Cancer J Clin. 51:2001;15-36
2. Ries L.A.G., Eisner M.P., Rosary C.L., et al. SEER cancer statistics review, 1973-1998. 2000;National Cancer Institute, Bethesda, MD
3. Handley W.S. The pathology of melanotic growths in relation to their operative treatment. Lancet. 1:1907;927-935
4. Handley W.S. The Hunterian lectures on the pathology of melanotic growths in relation to their operative treatment. Lancet. 1:1907;996-1003
5. Adair F.E. Treatment of melanoma report of five hundred cases. Surg Gynecol Obstet. 62:1936;4009
6. Pack GT, Scharnagel I, Morfit M. Principle of excision & dissection in continuity for primary and metastatic melanoma of skin surgery. Surgery 1945;17:849-66
7. Cameron J.R. Melanoma of the skin Clinical account of series of 209 malignant melanomas and skin. J R Coll Surg Edinb. 13:1968;233-254
8. Pringle J.H. A method of operation in cases of melanotic tumors of the skin. Edinb Med J. 23:1908;496-499
9. Breslow A., Macht S.D. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet. 145:1977;691-692
10. Balch C.M., Murad T.M., Soong S.-J., et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer. 43:1979;883-888
11. Aitken D.R., James A.G., Carey L.C. Local cutaneous recurrence after conservative excision of malignant melanoma. Arch Surg. 119:1984;643-646
12. Cascinelli N., van der Esch E.P., Breslow A., et al. WHO Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma. Stage I melanoma of the skin the problem of resection margins. Eur J Cancer Clin Oncol. 16:1984;1079-1085
13. Cosimi A.B., Sober A.J., Mihm M.C., et al. Conservative surgical management of superficially invasive cutaneous melanoma. Cancer. 53:1984;1256-1259
14. Elder D.E., Guerry D. IV, Heilberger R.M., et al. Optimal resection margin for cutaneous melanoma. Plast Reconstr Surg. 71:1983;66-72
15. Everall J.D., Dowd P.M. Diagnosis, prognosis and treatment of melanoma. Lancet. 2:1977;286-289
16. Kelly J.W., Sagebiel R.W., Calderon W., et al. The frequency of local recurrence and microsatellites as a guide to re-excision margins for cutaneous malignant melanoma. Ann Surg. 200:1984;759-763
17. Taylor B.A., Hughes L.E. A policy of selective excision for primary cutaneous malignant melanoma. Eur J Surg Oncol. 11:1985;7-13
18. Veronesi U., Bajetta E., Cascinelli N., et al. New trends in the treatment of malignant melanoma. Int Adv Surg Oncol. 1:1978;113-156
19. Day C.L. Jr, Mihm M.C. Jr, Sober A.A.J., et al. Narrower margins for clinical stage I malignant melanoma. N Engl J Med. 306:1982;479-482
20. Veronesi U., Cascinelli N., Adamus J., et al. Thin stage I primary cutaneous malignant melanoma comparison of excision with margins of 1 or 3 cm. N Engl J Med. 318:1988;1159-1162
21. Veronesi U., Cascinelli N., Adamus J., et al. Narrow excision (1 cm margin) a safe procedure for thin cutaneous melanoma. The results of an international randomized clinical trial. Arch Surg. 126:1991;438-441
22. Heenan P.J., Ghaznaure M. The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg. 52:1999;209-213
23. Harrist T.J., Rigel D.S., Day C.L., et al. Microscopic satellites are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 53:1984;2183-2187
24. Day C.L., Harrist T.J., Gorstein F., et al. Malignant melanoma prognostic significance of microscopic satellites in the reticular dermis and subcutaneous fat. Ann Surg. 194:1981;108-112
25. Leon P., Daly J.M., Synnestvedt M., et al. The prognostic implications of microscopic satellites in patients with stage I melanoma. Arch Surg. 126:1991;1461-1468
26. Day C.L., Mihm M.C., Lew R.A., et al. Prognostic factors for patient with clinical stage I melanoma and intermediate thickness (1.51-3.94 mm) a conceptual mode of tumor growth and metastases. Ann Surg. 195:1982;35-43
27. Roses D.F., Harris M.N., Rigel D., et al. Localized in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg. 198:1983;65-69
28. Balch C.M., Murad T.M., Soong S.-J., et al. A multifactorial analysis of melanoma prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 188:1978;732-742
29. Balch C.M., Soong S.-J., Milton G.W., et al. A comparison of prognostic factors and surgical results in 1786 patient with localized (stage one) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg. 196:1982;677-684
30. Balch C.M., Soong S.-J., Shaw H.M., et al. Analysis of prognostic factors in 850 patients with cutaneous melanoma. Balch C.M., Houghton A.N., Milton G.W.,, et al. Cutaneous melanoma. 1992;165-176 JB Lippincott, Philadelphia
31. Olsen G. The malignant melanoma of the skin. Acta Chir Scand. 365:(Suppl):1966;1-222
32. Kenady D.E., Brown B.W., McBride C.M. Excision of underlying fascia with a primary malignant melanoma effect on recurrence and survival rates. Surgery. 92:1982;615-618
33. Cascinelli N., van der Esch E.P., Breslow A., et al. Stage I melanoma of the skin the problem of resection margins. WHO Collaborating Center for evaluation of methods of diagnosis and treatment of melanoma. Eur J Cancer. 16:1980;1079-1085
34. Hansen M.G., McCarten A.B. Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Surg. 128:1974;557-561
35. Zeitels J., La Rossa D., Hamilton R., et al. A comparison of local occurrences and resection margins for stage I primary cutaneous malignant melanomas. Plast Reconstr Surg. 81:1988;688-693
36. Heenan P.J., English D.R., Holman C.D.J., et al. The effects of surgical treatment on survival and local recurrences of cutaneous malignant melanoma. Cancer. 69:1992;421-426
37. Kitayay D., Pixe O., et al. Surgical margins in cutaneous melanoma (2.1 cm versus 5 cm for lesions measuring less than 2.1 mm thick). Cancer. 97:2003;1941-1946
38. Vrisy M., Balch C.M., Soong S.-J., et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer. 55:1985;1398-1402
39. Balch C.M., Vrisi M.M., Kazakousis C.P., et al. Efficacy of 2 cm surgical margins for intermediate thickness melanomas (1 to 4 mm). Ann Surg. 218:1993;262-269
40. Heaton K.M., Sussman J.S., Gershenwald J.E., et al. Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Ann Surg Oncol. 514:1998;322-328
41. Ringborg U., Anderson R., Eldh J., et al. Resection margins of 2 versus 5 cm for cutaneous malignant with a tumor thickness of 0.8 to 2.0 mm. Cancer. 77:1996;1809-1814
42. Cohn-Ledermark G., Rutqvist L.E., Anderson R., et al. Long term results of a randomized study by the Swedish melanoma study group on 2 cm versus 5 cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer. 89:2000;1495-1501
43. Balch C.M., Soong S.-J., Smith T., et al. Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1.4 mm melanomas. Ann Surg Oncol. 8:2001;101-107
44. Backrishnan R., Hill A., Feldman S., et al. Efficacy, safety, and cost of office-based surgery. Dermatol Surg. 29:2003;1
45. Coldiron B. Office surgical incidents 19 months of Florida data. Dermatol Surg. 28:2002;710-713
46. Cook J.C., Perone J.B. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol. 139:2003;143-152
47. Vrisi M.M., Balch C.M., Soong S.-J., et al. Head and neck melanoma in 534 clinical stage I patients. A prognostic factor analysis and results of surgical treatment. Ann Surg. 200:1984;769-775
48. Agarwal-Antal N., Bowen G.M., Gerwels J.W. Histological evaluation of lentigo maligna with permanent sections implications regarding current guidelines. J Am Acad Dermatol. 45:2002;743-748
49. Zitelli J.A., Brown C.B., Hanusa B.H. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol. 37:1997;236-245
50. Robinson S.K. Margin control for lentigo maligna. J Am Acad Dermatol. 31:1994;79-85
51. Cohen L.M., McCall M.W., Hodge S.J., et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs micrographic surgery aided by rush permanent sections. Cancer. 73:1994;2964-2970
52. Zalla M.J., Kim K.K., Dicaudo D.J., et al. Mohs micrographic excision and melanoma using immunostains. Dermatol Surg. 26:2000;771-784
53. National Institutes of Health Consensus Conference. Diagnosis and treatment of early melanoma. JAMA. 268:1992;1314-1319
54. Zitelli J.A., Brown C.D., Hanusa B.H. Surgical margins for the excision of primary cutaneous melanoma. J Am Acad Dermatol. 37:1997;422-429
55. O'Leary J.A., Berend K.R., Johnson J.L., et al. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop. 378:2000;206-212
56. Pack G., Oropeza R. Subungual melanoma. Surg Gynecol Obstet. 124:1967;571-582
57. Brodland D. The treatment of nail apparatus melanoma with Mohs micrographic surgery. Dermatol Surg. 27:2001;269-273
58. Griego R., Zitelli J.A. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg. 24:1998;1003-1006
59. Milton G.W., Shaw H.M., McCarthy W.H. Resction margins for melanoma. Aust NZ J Surg. 55:1985;225-228
60. Carucci A. Mohs' micrographic surgery for the treatment of melanoma. Dermatol Clin. 20:2002;701-708
61. Mohs F.E. Chemosurgical treatment of melanoma a microscopically controlled method of excision. Arch Dermatol. 62:1950;269-279
62. Rowe D.E., Carroll R.J., Day C.L. Long-term recurrence rate in previously untreated (primary) basal cell carcinoma implications for patient follow-up. J Dermatol Surg Oncol. 15:1989;315-336
63. Parker T.L., Zitelli J.A. Surgical margins for excision of dermatofibromasarcoma protuberans. J Am Acad Dermatol. 32:1999;233-236
64. Ratz J.L., Duong S.L., Kulwin D.R. Sebaceous carcinoma of the eyelid treated with Mohs surgery. J Am Acad Dermatol. 14:1986;668-673
65. Fleischmann H.E., Roth R.J., Wood C., et al. Microcystic adnexal carcinoma treated by microscopically controlled excision. J Dermatol Surg Oncol. 10:1984;873-875
66. Bumstead R.M., Ceilley R.I. Auricular malignant neoplasms. Arch Otolaryngol. 108:1982;225-231
67. Mohs F.E. Fixed tissue micrographic surgery for melanoma of the ear. Arch Otolaryngol Head Neck Surg. 114:1988;625-631
68. Zitelli J.A., May R.L., Abel E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol. 24:1991;102-106
69. Goldminz D., Bennet R. Treatment results of lentigo maligna and lentigo maligna melanoma treated with Mohs micrographic surgery. J Dermatol Surg Oncol. 17:1991;767-771
70. Menaker G.M., Chiang J.K., et al. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma. J Am Acad Dermatol. 44:2001;833-836
71. Cohen L.M., McCall M.W., Zax R.H. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. Dermatol Surg. 24:1998;673-677
72. Snow S.N., Mohs F.E., Oriba H.A., et al. Cutaneous malignant melanoma treated by Mohs surgrey. Dermatol Surg. 23:1977;1055-1060
73. Braun M. Unreliability of frozen sections in the histologic evaluation of malignant melanoma. J Dermatol Surg Oncol. 12:1986;641
74. Dzubow L.M. Mohs surgery and melanoma. J Dermatol Surg Oncol. 12:1986;641
75. Barlow R.J., White C.R., Swanson N.A. Mohs micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol. 146:2002;290-294
76. Gross E.A., Andersen W.K., Rogers G.S. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol. 135:1999;15-17
77. Cook J., Zitelli J.A. Mohs micrographic surgery a cost analysis. J Am Acad Dermatol. 39:1998;698-703